SynBiotic SE (FRA:SBX)
Germany · Delayed Price · Currency is EUR 3.170
+0.060 (1.93%)
Last updated: Aug 12, 2025
Paramount Global Revenue
In the year 2023, SynBiotic SE had annual revenue of 3.86M EUR, down -52.71%. SynBiotic SE had revenue of 3.55M in the quarter ending June 30, 2024.
Revenue
3.86M
Revenue Growth
-52.71%
P/S Ratio
6.34
Revenue / Employee
70.21K
Employees
55
Market Cap
24.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.86M | -4.30M | -52.71% |
| Dec 31, 2022 | 8.17M | -898.09K | -9.91% |
| Dec 31, 2021 | 9.06M | 3.59M | 65.63% |
| Dec 31, 2020 | 5.47M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 78.30B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Energy AG | 38.39B |
| Rheinmetall AG | 10.67B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Deutsche Bank Aktiengesellschaft | 30.07B |
SynBiotic SE News
- 15 days ago - SynBiotic Eyes Triple Revenue by 2027 in Cannabis & Hemp Markets - Wallstreet:Online
- 4 months ago - EQS-DD: SYNBIOTIC SE: HempConsult GmbH, Lending (free of charge) of 50,000 shares as part of a securities lending programme. - Wallstreet:Online